| Pharmaceutical Information |
| Drug Name |
Gadodiamide |
| Drug ID |
BADD_D00985 |
| Description |
Gadodiamide is a paramagnetic gadolinium-based contrast agent (GBCA) that is used in MR imaging procedures to assist in the visualization of blood vessels. It is intravenously injected and is commonly marketed under the trade name Omniscan. |
| Indications and Usage |
For intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions), spine, and associated tissues. |
| Marketing Status |
approved; investigational |
| ATC Code |
V08CA03 |
| DrugBank ID |
DB00225
|
| KEGG ID |
D04284
|
| MeSH ID |
C064925
|
| PubChem ID |
60754
|
| TTD Drug ID |
D03EEH
|
| NDC Product Code |
0407-0691; 0407-0690; 71806-069 |
| UNII |
84F6U3J2R6
|
| Synonyms |
gadodiamide | Gd-DTPA bis-(methylamide) | Gd-DTPA-BMA | Omniscan | Omniscan Unique Softpack |
|
| Chemical Information |
| Molecular Formula |
C16H28GdN5O9 |
| CAS Registry Number |
122795-43-1 |
| SMILES |
CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
